
Ensysce Biosciences (ENSC) P/E Ratio
P/E Ratio as of Jul 3, 2025: -0.36
Average-0.3452
Median-0.3500
Minimum-0.3700
Maximum-0.3200
-0.36
Past Month0.00 (0.00%)
The P/E ratio for Ensysce Biosciences (ENSC) is -0.36 as of Jul 3, 2025. This represents a increase of 44.00% compared to its 12-month average P/E ratio of -0.25. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Ensysce Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Ensysce Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ensysce Biosciences to industry peers.
Ensysce Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Ensysce Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ensysce Biosciences to industry peers.
Ensysce Biosciences (ENSC) P/E Ratio Insights
See Ensysce Biosciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Ensysce Biosciences (ENSC)
Order type
Buy in
Order amount
Est. shares
0 shares
Ensysce Biosciences (ENSC) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $2.24 | -0.35 |
Jun 2, 2025 | $2.22 | -0.35 |
May 1, 2025 | $2.97 | -0.23 |
Apr 1, 2025 | $2.50 | -0.19 |
Mar 3, 2025 | $5.33 | -0.20 |
Feb 3, 2025 | $6.60 | -0.24 |
Jan 2, 2025 | $8.25 | -0.30 |
Ensysce Biosciences (ENSC) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.36 | +20.00% |
2024 | -0.30 | +500.00% |
2023 | -0.05 | +25.00% |
2022 | -0.04 | -98.74% |
2021 | -3.17 | -117.14% |
2020 | 18.49 | — |
FAQs About Ensysce Biosciences (ENSC) P/E ratio
The latest P/E ratio of Ensysce Biosciences (ENSC) is -0.36, as of Jul 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Ensysce Biosciences’s last 12-month average P/E ratio is -0.25, compared to its current P/E ratio of -0.36. This reflects a increase of 44.00%.
Ensysce Biosciences’s current P/E ratio of -0.36 is higher than its last 12-month average P/E of -0.25. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Ensysce Biosciences’s average P/E ratio over the last 3 years is -0.17. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Ensysce Biosciences’s average P/E ratio over the last 5 years is -86.77. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.